£490.00

It has never been this cheap. We have no record of a lower price.

£490 today · cheaper than every other day in the last 3 months

Non-Hodgkin and Chronic Lymphoma Treatment Outlook 2023-2028

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 26 days · 26 data points (no recent data)

Historical
Generating forecast…
£490.00 £465.50 £475.30 £485.10 £494.90 £504.70 £514.50 03 August 2026 09 August 2026 15 August 2026 21 August 2026 28 August 2026
View at Amazon ↗

Price data last checked 65 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 26 days • 1 price levels

Days at Price
26 days 0 7 13 20 26 £490 Days at Price

Price Analysis

Most common price: £490 (26 days, 100.0%)

Price range: £490 - £490

Price levels: 1 different prices over 26 days

Description

This statistical study provides a detailed outlook for non-Hodgkin's lymphoma and chronic lymphoma treatments across the United States from 2023 to 2028. The report identifies latent demand, also known as potential industry earnings (P.I.E.), across 10,833 specific US zip codes. By delivering estimates in millions of U.S. dollars, this data helps professionals understand market opportunities at a granular level. Users can access comparative benchmarks for every zip code, including its percent share relative to both its state and the entire United States. This specific statistical approach allows for quick gauging of one zip code against others, making it a useful tool for distribution and strategic planning. This comprehensive report by ICON Group International, Inc. offers the high-level data necessary for analyzing market trends in lymphoma treatments.

Key Features

Provides latent demand estimates in millions of U.S. dollars for non-Hodgkin's and chronic lymphoma treatments.

Covers a massive dataset spanning 10,833 zip codes across the United States.

Includes potential industry earnings (P.I.E.) estimates to help identify market opportunities.

Offers comparative benchmarks by reporting the percent share of each zip code relative to its state and the U.S.

Delivers a long-term outlook for the treatment market covering the years 2023 through 2028.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
09 January 2023
Listed Since
27 January 2023

Similar Products You Might Like

Non-Hodgkin Lymphoma Treatment Outlook 2023-2028 Study
99% match

Non-Hodgkin Lymphoma Treatment Outlook 2023-2028 Study

£490.00 25 Aug 2026
Non-Hodgkin Lymphoma US Zip Code Outlook 2023-2028
99% match

Non-Hodgkin Lymphoma US Zip Code Outlook 2023-2028

£490.00 28 Aug 2026
The 2023-2028 Outlook for Lymphoma Treatments for US Zip Codes
99% match

The 2023-2028 Outlook for Lymphoma Treatments for US Zip Codes

£490.00 28 Aug 2026
The 2023-2028 Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments in China
99% match

The 2023-2028 Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments in China

£495.00 22 Aug 2026
The 2023-2028 Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments in Japan
99% match

The 2023-2028 Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments in Japan

£495.00 21 Aug 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments in Japan
99% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments in Japan

£495.00 22 Aug 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma in China
99% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma in China

£495.00 02 Oct 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma in Japan
99% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma in Japan

£495.00 25 Aug 2026
The 2025-2030 World Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments
99% match

The 2025-2030 World Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments

£790.00 22 Aug 2026
The 2023-2028 Outlook for Lymphoma Treatments in China
99% match

The 2023-2028 Outlook for Lymphoma Treatments in China

£495.00 21 Aug 2026
The 2023-2028 Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments in India
99% match

The 2023-2028 Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments in India

£515.00 23 Aug 2026
The 2023-2028 Outlook for Lymphoma Treatments in the United States
98% match

The 2023-2028 Outlook for Lymphoma Treatments in the United States

£520.00 26 Aug 2026
The 2023-2028 Outlook for Lymphoma Treatments in India
98% match

The 2023-2028 Outlook for Lymphoma Treatments in India

£515.00 21 Aug 2026
The 2025-2030 World Outlook for Non-Hodgkin Lymphoma Treatments
98% match

The 2025-2030 World Outlook for Non-Hodgkin Lymphoma Treatments

£790.00 21 Aug 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments in the United States
98% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments in the United States

£520.00 13 Sep 2026
Lymphoma Therapeutics in Africa: 2013-2018 Outlook Study
98% match

Lymphoma Therapeutics in Africa: 2013-2018 Outlook Study

£325.00 03 Sep 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics in the United States
98% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics in the United States

£520.00 22 Aug 2026
Non-Hodgkin Lymphoma Chemotherapy Outlook in India 2023-2028
98% match

Non-Hodgkin Lymphoma Chemotherapy Outlook in India 2023-2028

£515.00 22 Aug 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics for US Zip Codes
97% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics for US Zip Codes

£490.00 02 Oct 2026
Non-Small Cell Lung Cancer Outlook 2023-2028 US Zip Codes
96% match

Non-Small Cell Lung Cancer Outlook 2023-2028 US Zip Codes

£490.00 26 Aug 2026
CML Treatment Outlook 2023-2028 - US Zip Code Analysis
96% match

CML Treatment Outlook 2023-2028 - US Zip Code Analysis

£490.00 28 Aug 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancers in China
96% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancers in China

£495.00 02 Oct 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in China
96% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in China

£495.00 01 Oct 2026